| 产品名称 |
重组Anti-IL-6抗体[EPR21711] (ab233706) |
| 宿主 |
Rabbit |
| 纯化方式 |
Protein A purified |
| 经测试应用 |
Flow Cyt (Intra), ICC/IF, IP, WB |
| 种属反应性 |
Human |
| 常规说明-背景资料 |
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free production
For more information see here.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents. |
| 阳性对照 |
WB: LPS/BFA-treated HUVEC whole cell lysate; Wild-type A549 IL-1ß (ab259387) (20 ng/ml, 24h) and Brefeldin A (ab120299)-treated (5 ug/ml for the last 4h) cell lysate ICC/IF: LPS/BFA-treated HUVEC cells. Flow Cyt (intra): LPS/BFA-treated HUVEC cells. IP: LPS/BFA-treated HUVEC whole cell lysate. |
| 形式 |
Liquid |
| 存放说明 |
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. |
| 存储溶液-重构 |
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol, 0.05% BSA |
| 纯度-浓度 |
批次浓度范围 100 µl 浓度为 0.442 - 0.453 mg/ml
批次浓度范围 40 µl 浓度为 0.442 - 0.453 mg/ml |
| 产品类型-克隆性 |
单克隆 |
| 克隆编号 |
EPR21711 |
| 偶联-标记 |
Unconjugated |
| 同种型-抗体亚型 |
IgG |
| 研究领域-补充信息 |
研究领域
Immunology Innate Immunity Cytokines InterleukinsNeuroscience Neurology process MetabolismMicrobiology Organism Virus RNA Virus ssRNA positive strand virus SARS CoronavirusCancer Invasion/microenvironment Angiogenesis Angiogenic growth factorsCancer Tumor immunology Cytokines InterleukinsMetabolism Types of disease ObesityMetabolism Types of disease Metabolic disordersNeuroscience Processes |
| 应用比例 |
The Abpromise guarantee
Abpromise™承诺保证使用ab233706于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。 |
| 理论分子量 |
predicted molecular weight: 23 kDa. |
| 检测分子量 |
Detects a band of approximately 21 kDa |
| 功能 |
Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation Acts on B-cells, T-cells, hepatocytes, hematopoeitic progenitor cells and cells of the CNS. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance. |
| 疾病相关 |
Genetic variations in IL6 are associated with susceptibility to rheumatoid arthritis systemic juvenile (RASJ) [MIM:604302]. An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis.
Note=A IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in HIV-infected men. |
| 序列相似性 |
Belongs to the IL-6 superfamily. |
| 翻译后修饰 |
N- and O-glycosylated. |
| 细胞定位 |
Secreted.
Target information above from: UniProt accession P05231
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010) . |
| 蛋白数据库链接-数据号 |
Entrez Gene: 3569 Human
Omim: 147620 Human
SwissProt: P05231 Human
Unigene: 654458 Human |
| 运输条件 |
Shipped at 4°C |
| 参考文献 |
文献 (60) |